期刊文献+

Alport综合征畸变产物耳声发射测试 被引量:3

Distortion product otoacoustic emission test in Alport syndrome
下载PDF
导出
摘要 目的 分析遗传性血尿肾病耳聋综合征(Alport syndrome,As)病人的听功能改变特点,畸变产物耳声发射(DPOAEs)测试的意义。方法 对10例As病人进行了纯音测听、声导抗、DPOAEs和听性脑干反应(ABR)测试。结果 As病人全部DPOAEs反应缺失或高频、中频振幅下降,声导抗测试10例病人鼓室压图均为A型曲线,除2例重度感音性耳聋病人声反射阈与听阈之差<60dB,提示Metz重振试验阳性外,其余病人各波潜伏期和波间期均在正常范围。结论 10例As病人DPOAEs均不正常,声导抗、ABR均能引出,验证了As病人耳部病变定位为耳蜗基底膜,与肾脏基底膜病变为共同靶器官,DPOAEs能反映耳蜗外毛细胞的功能微病理改变,对As的早期诊断、鉴别诊断及对遗传咨询有指导意义。 Objective To analyze the altered features of auditory functions of hereditary nephritis-nerve deafness syndrome (Alport syndrome, As) patients and the significance of distortion product otoacoustic emissions (DPOAEs) test. Methods All the As patients underwent the pure tone test, the acoustic immitance test, the DPOAEs test and ABR test. Results All the As patients were absent of DPOAEs response, but had a descendent high or intermediate frequency amplitude. The tympanogram of 10 patients were A-type curves in the acoustic immitance test. Two patients with severe sensory deafness had a margin less than 60 dB between the sound-reflection threshold and auditory threshold, indicating that the results of Metz loudness recruitment test were positive. Conclusion As patients have an abnormal result of DPOAEs test, whereas the results of acoustic immitance test and ABR test are normal; the location of pathological changes of As patients is the cochlea basilar membrane, which is one of the same target organs as the kidney basilar membrane. DPOAEs may reflect the micropathological alterations in the function of outer hair cells of cochlea, and may instruct the inchoate diagnosis, differential diagnosis and genetic counselling of As.
作者 刘清明 冯勃
出处 《中国耳鼻咽喉颅底外科杂志》 CAS 2003年第3期143-145,共3页 Chinese Journal of Otorhinolaryngology-skull Base Surgery
关键词 ALPORT综合征 畸变产物 耳声发射测试 听力丧失 Hereditary nephritis-nerve deafness syndrome (Alport syndrome, AS) Distortion product otoacoustic e- missions Alport syndroms/diag Hearing loss, sensormeural
  • 相关文献

参考文献4

  • 1黄选兆 汪吉宝.实用耳鼻咽喉科学[M].北京:人民卫生出版社,2001.220-223.
  • 2Lonsbury-Martin BL, McCoy MJ, Whitehead ML, et al. Clinical testing of distortion product otoacoustic emissions [J]. Ear Hear,1993, 1(1): 11-21.
  • 3Flinter F. Alport's syndrome[J]. J Med Genet, 1997, 34(4):326 - 330.
  • 4Tryggvason K, Heikkila P, Pettersson E, et al. Can Alport syndrome be treated by gene therapy? [ J ]. Kidney International,1997, 51(5): 1493- 1499.

共引文献40

同被引文献38

  • 1秦玉红,孙月华,翟立群,吕宏光,徐军.慢性肾功能不全血液透析患者的高频纯音听阈检测[J].临床耳鼻咽喉科杂志,2005,19(1):17-18. 被引量:3
  • 2窦艳玲,冯怀志,梁传余.庆大霉素耳毒性的临床听力学观察[J].听力学及言语疾病杂志,2005,13(5):372-373. 被引量:1
  • 3刘博,宋本波,赵小燕.耳鸣与耳声发射[J].中华耳鼻咽喉科杂志,1996,31(4):231-233. 被引量:26
  • 4钟乃川 见:黄选兆 汪吉宝主编.耳鸣[A].见:黄选兆,汪吉宝主编.实用耳鼻咽喉科学[C].北京:人民卫生出版社,1998.1222-1225.
  • 5Avan P, Bonfils P, Loth D, et al. Temporal pattens of transient-evoked otoacoustic emissions in normal and impaired clchleae. Hear Res,1993, 70 (1): 109-120.
  • 6Avan P, Bonfils P, Loth D, et al. Transient-evoked otoacoustic emissions and high-frequency acoustic trauma in the guinea pig. J Acoust Soc Am, 1995,97(5 Pt 1): 3012-3020.
  • 7Tamagawa Y, Ishikawa K, Ishikawa K, et al. Phenotype of DFNA11: a nonsyndromic hearing loss caused by a myosin ⅦA mutation. Laryngoscope, 2002, 112(2): 292-297.
  • 8Stern RE, Lalwani AK. Audiologic evidence for further genetic heterogeneity at DFNA2. Acta Otolaryngol, 2002, 122(7) :730-735.
  • 9Germain DP, Avan P, Chassaing A, et al. Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet, 2002, 3( 1): 10.
  • 10Hoth S. On a possible prognostic value of otoacoustic emissions: a study on patients with sudden hearing loss. Eur Arch Otorhinolaryngol, 2004, 5: 5.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部